Buyout Desk
Exit

Quad-C sells Boulder Scientific to Iron Path Capital

Longmont, Colorado-based maker of organometallic compounds and specialty chemicals; terms were not disclosed.

Quad-C Management has closed the sale of Boulder Scientific Company to Iron Path Capital, according to a press release dated November 11, 2026. Terms of the transaction were not disclosed.

Boulder Scientific, headquartered in Longmont, Colorado, manufactures high-performance organometallic compounds and provides complex synthetic chemistry capabilities. For more than six decades it has supplied specialty chemicals to the plastics, microelectronics, defense and aerospace industries. Quad-C partnered with the founding family and management team to support the company's transition from family ownership.

During Quad-C's ownership, Boulder Scientific strengthened its leadership team, made capital investments in its production facilities to expand capacity, and added capabilities serving semiconductor materials and aerospace and defense. CEO Rich Preziotti said Quad-C provided the resources and strategic support that positioned the company to grow. Piper Sandler served as exclusive financial adviser to Boulder Scientific and White & Case as its legal counsel.

Deal facts

Target
Boulder Scientific Company
Business
Specialty chemicals manufacturer of high-performance organometallic compounds and complex synthetic chemistry
Buyer
Iron Path Capital
Deal type
Exit
Headquarters
Longmont, Colorado
Advisers
  • Piper Sandler financial adviser to Boulder Scientific
  • White & Case legal counsel to Boulder Scientific
Status
Completed
Announced
Wednesday, November 11, 2026

Sources

Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.